These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 15880829)

  • 21. Hydroxychloroquine use reduces mortality risk in systemic lupus erythematosus: A systematic review and meta-analysis of cohort studies.
    Cai T; Zhao J; Yang Y; Jiang Y; Zhang JA
    Lupus; 2022 Dec; 31(14):1714-1725. PubMed ID: 36325952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical features, damage accrual, and survival in patients with familial systemic lupus erythematosus: data from a multi-ethnic, multinational Latin American lupus cohort.
    Quintana R; Pons-Estel GJ; Roberts K; Sacnún M; Serrano R; Nieto R; Conti S; Gervasoni V; Catoggio LJ; Soriano ER; Scolnik M; García MA; Alvarellos A; Saurit V; Berbotto GA; Sato EI; Costallat LTL; Neto EFB; Bonfa E; Xavier RM; de Oliveira E Silva Montandon AC; Molina-Restrepo JF; Iglesias-Gamarra A; Guibert-Toledano M; Reyes-Llerena GA; Massardo L; Neira OJ; Cardiel MH; Barile-Fabris LA; Amigo MC; Silveira LH; Torre IG; Acevedo-Vásquez EM; Ugarte-Gil MF; Alfaro-Lozano JL; Segami MI; Chacón-Díaz R; Esteva-Spinetti MH; Gomez-Puerta JA; Alarcón GS; Pons-Estel BA
    Lupus; 2020 Aug; 29(9):1140-1145. PubMed ID: 32605527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effect of hydroxychloroquine on infections in patients with systemic lupus erythematosus: an observational study using the LUNA registry.
    Hidekawa C; Yoshimi R; Saigusa Y; Tamura J; Kojitani N; Suzuki N; Sakurai N; Yoshioka Y; Sugiyama-Kawahara Y; Kunishita Y; Kishimoto D; Higashitani K; Sato Y; Komiya T; Nagai H; Hamada N; Maeda A; Tsuchida N; Hirahara L; Soejima Y; Takase-Minegishi K; Kirino Y; Yajima N; Sada KE; Miyawaki Y; Ichinose K; Ohno S; Kajiyama H; Sato S; Shimojima Y; Fujiwara M; Nakajima H
    Front Immunol; 2023; 14():1227403. PubMed ID: 37720209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine.
    Almeida-Brasil CC; Hanly JG; Urowitz M; Clarke AE; Ruiz-Irastorza G; Gordon C; Ramsey-Goldman R; Petri MA; Ginzler EM; Wallace DJ; Bae SC; Romero-Diaz J; Dooley MA; Peschken C; Isenberg D; Rahman A; Manzi S; Jacobsen S; Lim SS; van Vollenhoven R; Nived O; Jönsen A; Kamen DL; Aranow C; Sánchez-Guerrero J; Gladman DD; Fortin PR; Alarcon GS; Merrill JT; Kalunian K; Ramos-Casals M; Steinsson K; Zoma A; Askanase AD; Khamashta M; Bruce IN; Inanc M; Lukusa L; Bernatsky S
    Lupus Sci Med; 2022 Nov; 9(1):. PubMed ID: 36396267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort.
    Pons-Estel GJ; Alarcón GS; McGwin G; Danila MI; Zhang J; Bastian HM; Reveille JD; Vilá LM;
    Arthritis Rheum; 2009 Jun; 61(6):830-9. PubMed ID: 19479701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and Safety of Hydroxychloroquine Therapy for Systemic Lupus Erythematosus Patients Depend on Administration Dose.
    Wakiya R; Kameda T; Nakashima S; Shimada H; Fahmy Mansour MM; Kato M; Miyagi T; Kadowaki N; Dobashi H
    Intern Med; 2020 Sep; 59(17):2105-2112. PubMed ID: 32522920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between hydroxychloroquine levels and disease activity in a predominantly Hispanic systemic lupus erythematosus cohort.
    Geraldino-Pardilla L; Perel-Winkler A; Miceli J; Neville K; Danias G; Nguyen S; Dervieux T; Kapoor T; Giles J; Askanase A
    Lupus; 2019 Jun; 28(7):862-867. PubMed ID: 31122136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of systemic lupus erythematosus (SLE) Disease Activity Score and SLE Disease Activity Index 2000-based remission states in patients with SLE on damage accrual.
    Chitpet P; Chaiamnuay S; Narongroeknawin P; Asavatanabodee P; Leosuthamas P; Pakchotanon R
    Int J Rheum Dis; 2023 Dec; 26(12):2509-2516. PubMed ID: 37875327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of remission and its effect on damage and quality of life in Chinese patients with systemic lupus erythematosus.
    Mok CC; Ho LY; Tse SM; Chan KL
    Ann Rheum Dis; 2017 Aug; 76(8):1420-1425. PubMed ID: 28432050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A cross-sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus.
    Carmichael SJ; Day RO; Tett SE
    Intern Med J; 2013 May; 43(5):547-53. PubMed ID: 23425382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of post-partum damage accrual in systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (XXXVIII).
    Andrade RM; McGwin G; Alarcón GS; Sanchez ML; Bertoli AM; Fernández M; Fessler BJ; Apte M; Arango AM; Bastian HM; Vilá LM; Reveille JD;
    Rheumatology (Oxford); 2006 Nov; 45(11):1380-4. PubMed ID: 16880189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The risk of hospitalized infection in patients with systemic lupus erythematosus treated with hydroxychloroquine.
    Sakai R; Honda S; Tanaka E; Majima M; Konda N; Takada H; Harigai M
    Lupus; 2020 Nov; 29(13):1712-1718. PubMed ID: 32838624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restrictive Use of Oral Glucocorticoids in Systemic Lupus Erythematosus and Prevention of Damage Without Worsening Long-Term Disease Control: An Observational Study.
    Ruiz-Arruza I; Lozano J; Cabezas-Rodriguez I; Medina JA; Ugarte A; Erdozain JG; Ruiz-Irastorza G
    Arthritis Care Res (Hoboken); 2018 Apr; 70(4):582-591. PubMed ID: 28704598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The presumable effects of hydroxychloroquine and its metabolites in the treatment of systemic lupus erythematosus.
    Pan M; Jin R; Dai Y; Gao B; Liu Y; Peng X; Qiao J; Shuai Z
    Int Immunopharmacol; 2024 Jan; 126():111269. PubMed ID: 38006753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydroxychloroquine and Mortality Among Patients With Systemic Lupus Erythematosus in the General Population.
    Jorge A; McCormick N; Lu N; Zheng Y; Esdaile J; De Vera M; Choi H; Aviña-Zubieta JA
    Arthritis Care Res (Hoboken); 2021 Aug; 73(8):1219-1223. PubMed ID: 32407570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of organ damage in systemic lupus erythematosus: the Hopkins Lupus Cohort.
    Petri M; Purvey S; Fang H; Magder LS
    Arthritis Rheum; 2012 Dec; 64(12):4021-8. PubMed ID: 22932985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Damage accrual in southern Chinese patients with systemic lupus erythematosus.
    Mok CC; Ho CT; Wong RW; Lau CS
    J Rheumatol; 2003 Jul; 30(7):1513-9. PubMed ID: 12858450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does hydroxychloroquine improve patient reported outcomes in patients with lupus?
    Jolly M; Sehgal V; Arora S; Azizoddin D; Pinto B; Sharma A; Devilliers H; Inoue M; Toloza S; Bertoli A; Blazevic I; Vilá LM; Moldovan I; Torralba KD; Mazzoni D; Cicognani E; Hasni S; Goker B; Haznedaroglu S; Bourre-Tessier J; Navarra SV; Clarke A; Weisman M; Wallace D; Mok CC
    Lupus; 2021 Oct; 30(11):1790-1798. PubMed ID: 34304629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time to diagnosis in systemic lupus erythematosus: Associated factors and its impact on damage accrual and mortality. Data from a multi-ethnic, multinational Latin American lupus cohort.
    Nieto R; Quintana R; Zavala-Flores E; Serrano R; Roberts K; Catoggio LJ; García MA; Berbotto GA; Saurit V; Bonfa E; Borba EF; Lavras Costallat LT; Da Silva NA; Sato EI; Tavares Brenol JC; Massardo L; Neira OJ; Vázquez G; Guibert Toledano M; Pascual-Ramos V; Sauza Del Pozo MJ; Barile-Fabris LA; Amigo MC; García De La Torre I; Acevedo-Vásquez EM; Segami MI; Chacón-Díaz R; Esteva-Spinetti MH; Alarcón GS; Pons-Estel BA; Pons-Estel GJ
    Lupus; 2024 Apr; 33(4):340-346. PubMed ID: 38334100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus.
    Penn SK; Kao AH; Schott LL; Elliott JR; Toledo FG; Kuller L; Manzi S; Wasko MC
    J Rheumatol; 2010 Jun; 37(6):1136-42. PubMed ID: 20436082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.